It's long been 'mostly unknown' how genes impact depression. We just got a step closer
A team of international researchers, including Australians, analysed data from 29 countries across the world and uncovered ...
BioWorld1 天
J&J putting up $14.6B to grab Intra-Cellular, Caplyta
Intra-Cellular recently guided to at least $5 billion in peak Caplyta sales. Intra-Cellular’s stock was trading at $127.48, up $32.61, or 34%. J&J’s stock (NYSE:JNJ) was selling for $143.39, up $1.34.
HMNC Brain Health Completes Patient Randomization for Phase 2b OLIVE Trial for Major ...
Axis-Related DepressionMUNICH, Jan. 10, 2025 (GLOBE NEWSWIRE) -- HMNC Brain Health (“HMNC”), a clinical-stage precision psychiatry biopharma company pioneering personalized treatments powered by ...